Recce Pharmaceuticals secures approval for Phase 3 trial of R327G in Indonesia
Recce Pharmaceuticals Limited (ASX: RCE) has achieved a significant milestone in its quest to tackle diabetic foot infections (DFIs), a common complication among diabetes patients. ... Read More